Karyopharm Therapeutics Inc (KPTI) Insider Trading
- $10,245,912.22
- $142,179,299.35
- Sept. 15, 2025
- Ltd Chione
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Sept. 18, 2014 | Major Shareholder | 12,347 | $40.24 | Sell | $496,843.28 | |
| Sept. 17, 2014 | Major Shareholder | 9,569 | $40.26 | Sell | $385,247.94 | |
| Sept. 12, 2014 | Major Shareholder | 4,312 | $41.12 | Sell | $177,309.44 | |
| Sept. 8, 2014 | Major Shareholder | 35,666 | $39.92 | Sell | $1,423,786.72 | |
| Sept. 4, 2014 | Major Shareholder | 12,795 | $38.07 | Sell | $487,105.65 | |
| Aug. 27, 2014 | Major Shareholder | 43,699 | $38.80 | Sell | $1,695,521.20 | |
| Aug. 25, 2014 | Major Shareholder | 4,389 | $38.08 | Sell | $167,133.12 | |
| Aug. 15, 2014 | Major Shareholder | 8,027 | $39.11 | Sell | $313,935.97 | |
| Aug. 11, 2014 | Major Shareholder | 36,979 | $37.30 | Sell | $1,379,316.70 | |
| July 30, 2014 | Major Shareholder | 21,570 | $36.20 | Sell | $780,834.00 | |
| July 29, 2014 | Major Shareholder | 30,000 | $35.20 | Sell | $1,056,000.00 | |
| July 23, 2014 | Insider | 500,000 | $35.54 | Sell | $17,770,000.00 | |
| July 2, 2014 | CEO | 200,000 | $42.50 | Sell | $8,500,000.00 | |
| June 18, 2014 | Insider | 20,000 | $41.76 | Sell | $835,200.00 | |
| June 17, 2014 | CEO | 20,000 | $41.76 | Sell | $835,200.00 | |
| May 23, 2014 | Director | 114,419 | $26.18 | Buy | $2,995,489.42 | |
| May 13, 2014 | SVP | 1,000 | $28.06 | Buy | $28,060.00 | |
| Nov. 12, 2013 | Director | 312,500 | $16.00 | Buy | $5,000,000.00 |
Insiders are both buying and selling Karyopharm Therapeutics Inc stock.
The insider traders at Karyopharm Therapeutics Inc are: Ltd Chione, Michael Kauffman, Sharon Shacham, Richard A Paulson, Christopher Brett Primiano, Mansoor Raza Mirza, Marcin Czernik, Michael Mason, Deepika Pakianathan, Stuart Poulton, Sohanya Roshan Cheng, Jatin Shah, Reshma Rangwala, Ran Frenkel, Kristin Abate, Michael Mano, Garen G Bohlin, Stephen Mitchener, Tanya Lewis, John Demaree, Justin A Renz, Ltd Plio, Paul Brannelly, Paulson Richard A., and Barry E Greene
The most active insider trader at Karyopharm Therapeutics Inc is Ltd Chione with 36 trades.
Ltd Chione has sold the most Karyopharm Therapeutics Inc stock with a total value of $91,689,798.39.
Deepika Pakianathan has bought the most Karyopharm Therapeutics Inc stock with a total value of $10,995,453.42.
The most recent insider trade for Karyopharm Therapeutics Inc was on Sept. 15, 2025.
The single biggest insider buy for Karyopharm Therapeutics Inc was from Deepika Pakianathan with a total value of $5,000,000.00 on Nov. 12, 2013.
The single biggest insider sell for Karyopharm Therapeutics Inc was from Ltd Plio with a total value of $17,770,000.00 on July 23, 2014.